Saudi Arabia Schizophrenia Drugs Market Size & Outlook
Related Markets
Saudi Arabia schizophrenia drugs market highlights
- The Saudi Arabia schizophrenia drugs market generated a revenue of USD 59.8 million in 2024 and is expected to reach USD 83.6 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 6.1% from 2025 to 2030.
- In terms of segment, second generation antipsychotics was the largest revenue generating class in 2024.
- Third Generation Antipsychotics is the most lucrative class segment registering the fastest growth during the forecast period.
Schizophrenia drugs market data book summary
| Market revenue in 2024 | USD 59.8 million |
| Market revenue in 2030 | USD 83.6 million |
| Growth rate | 6.1% (CAGR from 2025 to 2030) |
| Largest segment | Second generation antipsychotics |
| Fastest growing segment | Third Generation Antipsychotics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Second Generation Antipsychotics, Third Generation Antipsychotics |
| Key market players worldwide | Johnson & Johnson, Bristol-Myers Squibb Co, AstraZeneca PLC, Sumitomo Dainippon Pharma Oncology, Eli Lilly and Co, Alkermes PLC, Allergan, Pfizer Inc, H. Lundbeck AS Class A |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.7% of the global schizophrenia drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa schizophrenia drugs market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 96.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Schizophrenia Drugs Market Scope
Schizophrenia Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alkermes PLC | View profile | 2100 | 1 Burlington Road, Connaught House, Dublin, Ireland, D04 C5Y6 | https://www.alkermes.com |
| Sumitomo Dainippon Pharma Oncology | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | https://www.sdponcology.com/ |
| H. Lundbeck AS Class A | View profile | 5700 | Ottiliavej 9, Valby, Denmark, 2500 | https://www.lundbeck.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | http://www.allergan.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Saudi Arabia schizophrenia drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to schizophrenia drugs market will help companies and investors design strategic landscapes.
Second generation antipsychotics was the largest segment with a revenue share of 76.09% in 2024. Horizon Databook has segmented the Saudi Arabia schizophrenia drugs market based on second generation antipsychotics, third generation antipsychotics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia schizophrenia drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia schizophrenia drugs market databook
-
Our clientele includes a mix of schizophrenia drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia schizophrenia drugs market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia schizophrenia drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia schizophrenia drugs market size, by class, 2018-2030 (US$M)
Saudi Arabia Schizophrenia Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
